Genpharmasec Ltd
Genpharmasec Ltd (GENPHARMA) last traded at ₹1.01, a market capitalisation of ₹55.9 crore. Over the past 52 weeks the stock has ranged between ₹0.75 and ₹2.15. Genpharmasec Ltd last reported results for the quarter ended Jun 2026, with sales of ₹49.71 crore and net profit of ₹-0.17 crore. Figures are as of 25 Aug 2026 and are not real time.
Genpharmasec Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Genpharmasec Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹49.71 cr, up 312.9% from ₹12.04 cr a year earlier. Net profit swung to a loss of ₹0.17 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 6.03 | 8.48 | 14.01 | 12.04 | 32.64 | 39.83 | 55.43 | 49.71 |
| Expenses | 5.9 | 7.76 | 15.01 | 11.1 | 33.1 | 41.07 | 53.44 | 48.75 |
| Operating profit | 0.13 | 0.72 | -1 | 0.94 | -0.46 | -1.24 | 1.99 | 0.96 |
| OPM % | 2.16% | 8.49% | -7.14% | 7.81% | -1.41% | -3.11% | 3.59% | 1.93% |
| Other income | 0.75 | 0.81 | 0.94 | 0.69 | 0.46 | 0.98 | 1.02 | 0.37 |
| Interest | 0.07 | 0.16 | 0.11 | 0.12 | 0.23 | 0.41 | 0.48 | 0.4 |
| Depreciation | 0.3 | 0.1 | 0.26 | 0.27 | 0.56 | 0.67 | 0.68 | 0.67 |
| Profit before tax | 0.51 | 1.27 | -0.43 | 1.24 | -0.79 | -1.34 | 1.85 | 0.26 |
| Tax % | -39.22% | 40.16% | -37.21% | 2.42% | 48.10% | -37.31% | 27.03% | 165.38% |
| Net profit | 0.7 | 0.76 | -0.27 | 1.22 | -1.18 | -0.83 | 1.36 | -0.17 |
| EPS (₹) | 0.01 | 0.01 | -0.00 | 0.02 | -0.02 | -0.01 | 0.03 | 0.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Genpharmasec Ltd annual results
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 26 | 30 | 34 | 140 | 178 |
| Operating profit | 0 | 0 | 0 | 1 | 1 |
| OPM % | 1.0% | 0.1% | 0.2% | 0.9% | 0.7% |
| Net profit | 1 | -0 | 1 | 1 | -1 |
| EPS (₹) | 0.02 | -0.00 | 0.02 | 0.03 | -0.00 |
TTM is the trailing twelve months to the most recent quarter.
Genpharmasec Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 76%
- TTM
- 338%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 13%
- TTM
- -111%
- 10 Years
- 20%
- 5 Years
- -26%
- 3 Years
- -21%
- 1 Year
- -49%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 2%
- Last Year
- 2%
Genpharmasec Ltd shareholding pattern
Promoters held 29.98% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% |
| Public | 70.02% | 70.02% | 70.02% | 70.02% | 70.03% | 70.01% | 70.02% | 70.02% |
| No. of shareholders | 1,05,838 | 1,09,206 | 1,09,080 | 1,07,602 | 1,05,804 | 1,04,021 | 1,02,252 | 1,01,134 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Genpharmasec Ltd corporate filings
- Regarding Recent Agreement with Amneal Healthcare Private LimitedCompany Updatemedium impact
Cruxal's analysis: Genpharmasec Ltd has announced a formal agreement with Amneal Healthcare Private Limited…
Read the full analysis - Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026.Company Updatelow impact
Cruxal's analysis: Genpharmasec Limited has published its unaudited standalone and consolidated financial…
Read the full analysis - Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026.Company Updatelow impact
Cruxal's analysis: Genpharmasec Limited has filed a statement confirming that there is no deviation or…
Read the full analysis - Outcome of the Meeting of Board of Directors held on Tuesday, 11th August, 2026.Board Meetinghigh impact
Cruxal's analysis: Genpharmasec Limited reported a consolidated net loss of 0.17 crore for the quarter ended…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Genpharmasec Ltd
Cruxal reads every Genpharmasec Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.